𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Failure to respond to interferon-α 2a therapy is associated with increased hepatic iron levels in patients with chronic hepatitis C

✍ Scribed by Fujito Kageyama; Yoshimasa Kobayashi; Gou Murohisa; Erina Shimizu; Fumitaka Suzuki; Masataka Kikuyama; Kenichi Souda; Tsunehisa Kawasaki; Hirotoshi Nakamura

Publisher
Humana Press Inc
Year
1998
Tongue
English
Weight
694 KB
Volume
64
Category
Article
ISSN
0163-4984

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum hepatitis C virus RNA level as a p
Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-α therapy in Japanese patients with chronic hepatitis C
✍ Etsuro Onto; Masashi Mizokami; Tatsunori Nakano; Hisahiro Terashima; Osamu Nojir 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 1 views

## Abstract Serum hepatitis C virus (HCV) RNA level has been shown to be a good predictor of subsequent response to interferon‐α (IFN) therapy in US patients in whom genotype 1a/1b are both predominant. To determine whether serum HCV RNA level is a predictor of subsequent response to IFN in Japanes

Hepatitis C virus genome complexity corr
Hepatitis C virus genome complexity correlates with response to interferon therapy: A study in French patients with chronic hepatitis C
✍ B Le Guen; G Squadrito; B Nalpas; P Berthelot; S Pol; C Brechot 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB 👁 2 views

Recent studies performed in Japan have suggested that hepatitis C virus (HCV) genome heterogeneity might be taken as a predictive virological parameter of response to interferon alfa (IFN-alpha) treatment. However, there is presently no information on the impact of this virological parameter in pati

Varying incidence of cirrhosis and hepat
Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy
✍ Michiko Shindo; Arai Ken; Tadao Okuno 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 3 views

## BACKGROUND. To determine whether interferon (IFN) therapy can reduce incidence of the development of cirrhosis and hepatocellular carcinoma equally in patients with chronic hepatitis C virus (HCV) who responded differently to therapy, a retrospective analysis of 250 patients treated with IFN wa